RareResearch.AI
← Back to atlas

G702S

Category 3/4 — Most DruggablePathogenic/Likely pathogenicLumenal · predictedσ-1 candidateEditorial
GlycineSerine at position 702 · C-terminal lumenal domain (653-869) · WFS1 (Wolframin)

A conserved glycine inside a tight lumenal hairpin gives way to serine — the loss of glycine's torsional freedom is the entire mechanism, and the neighboring Arg703 hydrogen-bond partner is the structural casualty.

Interactive 3D Structure

Wild-type reference
Wild-type G702 — hydrogen bond to I823
Fullscreen ↗
DynaMut2 mutant · G702S
Mutant S702 — polar contact contact to I823 lost
Fullscreen ↗

Bond changes · DynaMut2 interaction analysis

1 lost10 gained3 preserved
Interaction typeWild-type partnerMutant partnerStatus
Hydrogen bondV779Gained
Hydrogen bondG780Gained
Hydrogen bondM781Gained
Hydrogen bondL822L822Preserved
Hydrogen bondI823I823Preserved
Polar contactV779Gained
Polar contactG780Gained
Polar contactM781Gained
Polar contactL822Gained
Polar contactI823I823Preserved
CarbonylL822Gained
Van der WaalsV779Lost
Van der WaalsM781Gained
Van der WaalsL822Gained

Lost / gained / preserved interatomic contacts at the variant residue, from the DynaMut2 (Arpeggio) interaction analysis of the wild-type and energy-minimized mutant structures.

Computational Predictions

DynaMut2 ΔΔG
-1.25kcal/mol
Destabilising — moderate
AlphaMissense
0.944
LPath
AlphaFold pLDDT
89
model confidence
Schema
Cat 3/4
Category 3/4 — Most Druggable

Clinical Evidence

ClinVar classificationPathogenic/Likely pathogenic
Review statuscriteria provided, multiple submitters, no conflicts
Associated conditionsWolfram syndrome 1; Optic atrophy
InheritanceAutosomal recessive (Wolfram syndrome 1 form documented in ClinVar).
Population frequency (gnomAD v4)Ultra-rare · AF 0.0022%
cDNA changec.2104G>A
ClinVar accessionVCV001373337
Last evaluated2026/01/26 00:00

Observed at very low frequency in gnomAD.

Structural Context

G702 is wedged into a dense lumenal core. Its immediate covalent neighbors Arg703 (2.44 Angstrom) and Thr701 (2.45 Angstrom) flank it; the through-space contacts read like a packed hydrophobic-polar cluster — Val779 (3.50 Angstrom), Gly780 (3.54 Angstrom), Pro782 (3.76 Angstrom), Ile823 (3.89 Angstrom), Met781 (4.06 Angstrom), Phe825 (4.42 Angstrom). The Gly702-Gly780 pairing across 3.5 Angstrom is structurally interesting: two glycines in close apposition usually means a turn or hairpin that requires both backbones to adopt unusual phi/psi angles unavailable to other residues.

Replacing G702 with serine eliminates that geometric license. Serine has a beta-carbon and a hydroxyl, both compatible with standard Ramachandran space but incompatible with the disallowed-region phi/psi values that glycine populates here. The local backbone is forced to find a new conformation, and because Arg703 is the immediate downstream neighbor, the rearrangement carries Arg703's guanidinium with it — almost certainly displacing whatever salt bridge or hydrogen bond Arg703 contributes to the lumenal contact network with Pro782, Met781, or the Phe825 ring.

DynaMut2 returns DeltaDeltaG = -1.25 kcal/mol — destabilising and on the upper edge of the mild bucket. AlphaMissense 0.944 reads this as clearly pathogenic. The combination is consistent with a residue whose evolutionary indispensability is purely geometric: glycine is conserved at 702 not for any chemical contribution it makes but for the backbone freedom it provides. Any other residue, even one as conservative as serine, breaks the hairpin.

Clinically, G702S is documented in Wolfram syndrome 1 and optic atrophy — phenotypes that fit a lumenal-domain perturbation interfering with the ATF6 unfolded protein response axis. The fold survives; the function does not.

Amino-acid chemistry
Glycine (no side chain, uniquely permissive phi/psi geometry — the only amino acid that comfortably populates the disallowed Ramachandran region) to Serine (small polar hydroxyl, restricted to standard backbone angles) at position 702.
Position in the protein
Position 702 sits in wolframin's C-terminal lumenal domain (residues 653-869) — the ATF6-interacting, Na+/K+ ATPase beta1-contacting, calcium-sensing module that faces the ER lumen. pLDDT 88.75 places it inside a well-modeled region.

Druggability Assessment

Final classification: Category 3 — Most Druggable. pLDDT 88.75 puts G702 in an ordered, modelable region; the DeltaDeltaG magnitude (1.25 kcal/mol) is firmly inside the small-molecule rescue window; AlphaMissense 0.944 confirms strong functional constraint; and the disrupted contact set — Arg703 and its through-space partners around Pro782/Met781/Phe825 — is small and spatially defined. The therapeutic frame is a pharmacological chaperone that restores the hairpin geometry at the Gly702-Gly780 turn. CFTR-corrector-class molecules that bind misfolded membrane proteins and recover near-native geometry are the direct analogue. Importantly, the Atlas should treat the G702-G780 pair as a single targetable site: any compound that stabilizes the wild-type backbone arrangement at G702 likely also stabilizes G780 and the surrounding aromatic-aliphatic packing.

Why this matters

Glycine-loss variants are a recurring motif in the Atlas because glycine carries information that no other residue can substitute for — pure backbone freedom. When a glycine is conserved, the protein needs precisely the disallowed phi/psi space it provides, and substitution is mechanistically equivalent to a torsional restraint. G702S exemplifies the class. For wolframin specifically, position 702 sits in the same lumenal region as several other glycine-substitution variants documented in ClinVar. Mapping the constellation of glycine residues across the lumenal domain may identify a small set of hairpin sites that all share the same therapeutic logic: a single pharmacological chaperone could potentially rescue multiple Cat 3 glycine variants at once, which is precisely the kind of leverage the Atlas thesis predicts.
Therapeutic Strategy Handoff · prediction

Feed this card to Wolfram Intelligence

Download the G702S PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.

Download G702S PDF card ↓Strategies are AI-generated predictions, not validated therapeutics.

UniProt Domain Annotation

Chain1890 · Wolframin
Topological domain653869 · Lumenal